Free Trial

Allstate Corp Invests $2.20 Million in Synopsys, Inc. (NASDAQ:SNPS)

Synopsys logo with Computer and Technology background
Remove Ads

Allstate Corp bought a new position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the fourth quarter, according to its most recent filing with the SEC. The firm bought 4,533 shares of the semiconductor company's stock, valued at approximately $2,200,000.

Several other large investors also recently bought and sold shares of the stock. Kieckhefer Group LLC purchased a new position in shares of Synopsys in the fourth quarter worth about $27,000. Whipplewood Advisors LLC acquired a new position in Synopsys in the 4th quarter worth approximately $33,000. Sierra Ocean LLC purchased a new position in Synopsys during the 4th quarter worth approximately $39,000. Newbridge Financial Services Group Inc. acquired a new stake in Synopsys during the 4th quarter valued at approximately $51,000. Finally, Versant Capital Management Inc boosted its holdings in shares of Synopsys by 109.3% in the 4th quarter. Versant Capital Management Inc now owns 113 shares of the semiconductor company's stock valued at $55,000 after acquiring an additional 59 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company's stock.

Synopsys Stock Up 1.7 %

Shares of Synopsys stock traded up $7.09 on Tuesday, reaching $435.94. The company's stock had a trading volume of 985,635 shares, compared to its average volume of 1,049,297. Synopsys, Inc. has a 52-week low of $423.08 and a 52-week high of $624.80. The company has a market capitalization of $67.41 billion, a P/E ratio of 30.02, a PEG ratio of 3.23 and a beta of 1.16. The stock has a 50-day moving average price of $483.67 and a 200-day moving average price of $505.29.

Remove Ads

Analysts Set New Price Targets

SNPS has been the subject of several recent research reports. Rosenblatt Securities reissued a "buy" rating and set a $660.00 target price on shares of Synopsys in a report on Tuesday, February 25th. Morgan Stanley reduced their price objective on Synopsys from $625.00 to $590.00 and set an "overweight" rating for the company in a research note on Monday, February 24th. Redburn Atlantic began coverage on Synopsys in a research note on Monday, January 13th. They issued a "buy" rating and a $600.00 target price on the stock. Needham & Company LLC reiterated a "buy" rating and set a $650.00 price target on shares of Synopsys in a research report on Thursday, February 27th. Finally, Wells Fargo & Company lowered their price objective on Synopsys from $540.00 to $520.00 and set an "equal weight" rating on the stock in a research report on Thursday, February 27th. One analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $638.58.

Read Our Latest Report on SNPS

Insider Buying and Selling

In other news, insider Geus Aart De sold 15,705 shares of Synopsys stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $444.42, for a total value of $6,979,616.10. Following the sale, the insider now owns 116,671 shares in the company, valued at $51,850,925.82. This trade represents a 11.86 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Sassine Ghazi sold 11,366 shares of the company's stock in a transaction dated Monday, March 3rd. The stock was sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the transaction, the chief executive officer now owns 70,922 shares of the company's stock, valued at approximately $32,890,077.50. This trade represents a 13.81 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 47,909 shares of company stock valued at $22,794,835. 0.62% of the stock is owned by corporate insiders.

Synopsys Profile

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Further Reading

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

 5 Stocks to BUY NOW in April 2025
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads